PHARMESTE
PharmEste s.r.l., a biopharmaceutical company, engages in the discovery and development of transient receptor potential (TRP) channel therapeutics for the treatment of neuropathic pain, overactive bladder, and other TRP-mediated diseases. It develops PHE377, a TRPV1 antagonist for the treatment of neuropathic pain.
PHARMESTE
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2003-01-01
Address:
Bresso, Lombardia, Italy
Country:
Italy
Status:
Closed
Total Funding:
17.11 M USD
Investors List
Zcube
Zcube investment in Series B - PharmEste
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Series B - PharmEste
MPS Venture
MPS Venture investment in Series B - PharmEste
INGENIUM Emilia Romagna
INGENIUM Emilia Romagna investment in Series A - PharmEste
Fondamenta SGR
Fondamenta SGR investment in Series A - PharmEste